Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Review ArticleR
Open Access

Long Non-coding RNAs and their Role in Metastasis

ULRICH H. WEIDLE, FABIAN BIRZELE, GWEN KOLLMORGEN and RÜDIGER RÜGER
Cancer Genomics & Proteomics May 2017, 14 (3) 143-160;
ULRICH H. WEIDLE
1Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FABIAN BIRZELE
2Roche Innovation Center Basel, F. Hofman La Roche, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GWEN KOLLMORGEN
1Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RÜDIGER RÜGER
1Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ruediger.rueger@roche.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Mode of action of lncNKILA, Tre lncRNA, HOTAIR, MALAT1, GClncRNA, BCAR4 and lncRNA-ATP. (A) NKILA acts as a negative regulator of NFĸB signaling. IĸB, inhibitor of ĸB; NFĸB, nuclear factor ĸ; NKILA, NFĸB-activating lncRNA; p50 and p65, subunits of NFĸB. Blue circles indicate polyubiquitinylation. (B) Tre lncRNA inhibits translation of pro-metastatic mRNAs via RNP formation by a poorly resolved mode of action. eIF-4G1, translation initiation factor 4G1; FXR1, FXR3, fragile X mental retardation syndrome-related proteins 1, 3; hnRNPK, heterogeneous ribonucleoprotein complex K; SF3B3, splicing factor 3B subunit 3; treRNA, translational regulatory RNA; treRNA RNP, tre RNA ribonucleoprotein complex. (C) HOTAIR represses gene expression by recruitment of PRC2 and LSD1 by increasing the repression code H3K27me3 and decreasing the activation code H3K4me3. DZIP3, DAZ interacting protein 3 (E3 ubiquitin-protein ligase); HOTAIR, HOX antisense intergenic RNA; H3K4me3, histone 3 trimethylated lysine 4; H3K27me3, histone 3 trimethylated lysine 27; LSD1, lysine-specific demethylase 1; PRC2, polycomb repressive complex 2. Blue circles indicate polyubiquitinylation. (D) MALAT1 relieves gene repression in polycomb bodies by replacement of TUG1 lncRNA and recruitment of co-activators in Interchromatin granules thus promoting G1/S transition. CoA, co-activator; CoR, co-repressor; CH3, methyl group; E2F, transcription factor 2F; MALAT1, metastasis-associated lung adenocarcinoma transcript; Pc2, polycomb 2; Pc2-CH3, methylated Pc2; SUMO, sumoylated; lnc RNA TUG1, lnc RNA taurine-upregulated gene 1. Red/green arrow: inhibition/activation of transcription; red circles indicate sumoylation. (E) GClncRNA recruits histone modifiers such as WDR5 and KAT2A for transactivation of transcription of selected genes. GC lncRNA, Gastric cancer lncRNA; KAT2A, lysine acetyltransferase 2A; WDR5, WD repeat containing protein 5; SOD2, superoxide dismutase 2. Green arrow, indicates activation of transcription. (F) BCAR4 mediates activation of phospho-GLI-2 dependent target genes. BCAR4, Breast cancer anti-estrogen resistance; CCL21, chemokine (C-C motif) ligand 21; CCR7, CC-chemokine receptor 7; GLI2, glioma-associated oncogene family zinc finger 2; p, phosphorylated; PNUTS, putative protein phosphatase 1 nuclear; Pol II, polymerase II; Pp1, phosphatase 1; p300, E1A binding protein 300; SNIP1, smad nuclear interacting protein 1. Black arrows indicate phosphorylation of GLI2 by CCR7/CCL21 interaction; green arrows indicate activation of transcription. (G) lncRNA – ATP mimics the prometastatic role of TGFβ biy inducing miR200 family members and promotes IL11 signaling. EMT, Epithelial mesenchymal transition; IL11, interleukin 11; lnc RNA – ATP, lncRNA activated by TGFβ; STAT3, signal transducer and activator of transcription 3; TGFβ, transforming growth factor β; blue circled P, phosphorylation.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    RNA steady-state levels of selected RNAs in different tumor entities. (A) H19; (B) MALAT1; (C) HOTAIR; (D) BCAR4; (E) MEG3. Expression in tumor/matching normal samples is shown for selected cohorts derived from The Cancer Genome Atlas (TCGA) database. Bladder cancer (408/19), breast cancer (1,100/112), colon cancer (475/41), liver cancer (373/50), lung adenocarcinoma (517/59), lung squamous carcinoma (501/51), prostate cancer (498/52) and stomach cancer (415/35). Expression is measured as normalized read counts, the red lines indicate low versus higher expression (~100 counts). Expression data are shown as box blots where the line in the middle of the box represents the data median, the rectangles show the upper and lower quartile (therefore, 50% of all data points are included in the rectangle). All other data points, except for outliers lie within the upper and lower whiskers. A value of -10 indicates no expression in the corresponding sample. For some tumor types not a single sample expressing the corresponding lncRNA was found.

PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 14 (3)
Cancer Genomics & Proteomics
Vol. 14, Issue 3
May-June 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Long Non-coding RNAs and their Role in Metastasis
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Long Non-coding RNAs and their Role in Metastasis
ULRICH H. WEIDLE, FABIAN BIRZELE, GWEN KOLLMORGEN, RÜDIGER RÜGER
Cancer Genomics & Proteomics May 2017, 14 (3) 143-160;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Long Non-coding RNAs and their Role in Metastasis
ULRICH H. WEIDLE, FABIAN BIRZELE, GWEN KOLLMORGEN, RÜDIGER RÜGER
Cancer Genomics & Proteomics May 2017, 14 (3) 143-160;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Long Non-coding RNA (lncrna) – General Features
    • Metastasis-related lncRNAs – Category I
    • Metastasis-related lncRNAs: Category II
    • Metastasis-related lncRNAs: Category III
    • Therapeutic Aspects
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Long Noncoding RNA NEAT1 Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways
  • NF-{kappa}B-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-{kappa}B Signaling
  • Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
  • Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesis
  • High glucose contributes to the proliferation and migration of non-small-cell lung cancer cells via GAS5-TRIB3 axis
  • Both High and Low Serum Total Testosterone Levels Indicate Poor Prognosis in Patients with Prostate Cancer
  • Google Scholar

Similar Articles

Keywords

  • Chromatin remodeling
  • decoy function
  • DNA-RNA interaction
  • epigenetic modification
  • guide function
  • nucleic acid-based therapy
  • protein-RNA interaction
  • RNA-RNA interaction
  • scaffold function
  • signaling networks
  • review
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire